Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
IBB vs PVAL: how they differ
IBB and PVAL hold 1% of their weight in the same names, and IBB returned more over the year.
iShares Biotechnology ETF and Putnam Focused Large Cap Value ETF.
What they hold in common
By the books each fund has filed, IBB and PVAL hold 1% of their money in the same securities at the same weight.
| Holding | IBB | PVAL |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4.91% | 1.34% |
| Only in IBB | Only in PVAL |
|---|---|
| Vertex Pharmaceuticals, Inc. 8.09% | CISCO SYSTEMS INC 6.06% |
| Amgen, Inc. 7.84% | CITIGROUP INC 4.68% |
| Gilead Sciences, Inc. 6.85% | EXXON MOBIL CORP 3.66% |
| Argenx SE 3.76% | ALPHABET INC 3.33% |
| Alnylam Pharmaceuticals, Inc. 3.12% | ADVANCED MICRO DEVICES INC 3.09% |
| Natera, Inc. 2.89% | SEAGATE TECHNOLOGY HOLDINGS PLC 3.08% |
| Revolution Medicines, Inc. 2.78% | AMAZON.COM INC 2.96% |
| Biogen, Inc. 2.47% | MICROSOFT CORP 2.96% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 29, 2026.
| IBB iShares Biotechnology ETF | PVAL Putnam Focused Large Cap Value ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | Putnam |
| What it is | Biotechnology | Putnam Focused Large Cap Value |
| Total return, 1 year | +41.5% | +28.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +24.0 pts | +10.8 pts |
| Expense ratio | 0.44% | not published |
| Already in the S&P 500 | 35.6% | 94.9% |
| Holdings | 248 | 45 |
IBB in plain words
IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.
PVAL in plain words
PVAL is an index equity fund tracking the Putnam Focused Large Cap Value. Over the year to Sep 11, 2026 it returned +28.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. By its holdings filed for May 29, 2026, 95% of the fund by weight is stocks the S&P 500 also holds, across 45 positions, with the top ten at 35.6%.
Questions people ask
- Which returned more over the last year, IBB or PVAL?
- In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and PVAL returned +28.4%, so IBB returned more. One year is one year; the longer windows are in the table.
- How much do IBB and PVAL overlap with the S&P 500?
- By their latest filed holdings, 36% of IBB and 95% of PVAL by weight is stocks the S&P 500 already holds. Between the two funds, 1% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IBB against PVAL, data as of Sep 12, 2026. https://etfiq.com/compare/any/IBB-PVAL Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources